Literature DB >> 23142133

Pathogen sensors and chemokine receptors in dendritic cell subsets.

Tsuneyasu Kaisho1.   

Abstract

Pathogen sensors such as Toll-like receptors (TLRs) detect microorganism- or host-derived conserved molecular structures, including lipids or nucleic acids and provoke activation of Ag presenting cells such as dendritic cells (DCs). Several synthetic TLR ligands, especially oligonucleotides, are being developed as promising vaccines for infectious diseases, cancers or allergies. DCs are heterogeneous and consist of various subsets, each of which expresses a subset-specific repertoire of TLRs and responds to the TLR signaling in a subset-specific manner. Furthermore, each DC subset expresses a set of chemokine receptors that regulate its function and behavior. Here I review the functions of two DC subsets and how chemokine receptors function in these subsets. One is the plasmacytoid DC (pDC), which expresses nucleic acid sensing receptors TLR7 and TLR9 and secretes large amounts of type I interferons in response to TLR7/9 signaling. The other is splenic CD8α(+) conventional DC (cDC). This DC subset expresses lipid sensors, TLR2 and TLR4, and nucleic acid sensors, TLR3, TLR9 and TLR13 and is specialized for antigen crosspresentation. Several chemokine receptors are differentially expressed on these DC subsets. The homologues of these murine DC subsets are also found in humans. Understanding how these DC subsets function and respond to TLR ligands and chemokines should be important for development of effective vaccines.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142133     DOI: 10.1016/j.vaccine.2012.10.043

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

1.  The expression of Toll-like receptors 2, 4 and 9 in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

Authors:  H Wang; S-J Gou; M-H Zhao; M Chen
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

2.  Design and development of stable, water-soluble, human Toll-like receptor 2 specific monoacyl lipopeptides as candidate vaccine adjuvants.

Authors:  Deepak B Salunke; Seth W Connelly; Nikunj M Shukla; Alec R Hermanson; Lauren M Fox; Sunil A David
Journal:  J Med Chem       Date:  2013-07-10       Impact factor: 7.446

3.  CpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancer.

Authors:  Yumin Xia; Gaurav K Gupta; Ana P Castano; Pawel Mroz; Pinar Avci; Michael R Hamblin
Journal:  J Biophotonics       Date:  2013-08-07       Impact factor: 3.207

Review 4.  Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.

Authors:  Martha A Alexander-Miller
Journal:  J Immunol       Date:  2014-12-01       Impact factor: 5.422

5.  Direct and indirect engagement of dendritic cell function by antibodies developed for cancer therapy.

Authors:  Diana Corogeanu; Sandra S Diebold
Journal:  Clin Exp Immunol       Date:  2022-07-22       Impact factor: 5.732

6.  Glycan recognition by human blood mononuclear cells with an emphasis on dendritic cells.

Authors:  Eugenia M Rapoport; Sergey V Khaidukov; Andrey M Gaponov; Galina V Pazynina; Svetlana V Tsygankova; Ivan M Ryzhov; Ivan M Belyanchikov; Panagiota Milona; Nicolai V Bovin; Kenneth C McCullough
Journal:  Glycoconj J       Date:  2018-01-31       Impact factor: 2.916

Review 7.  Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer.

Authors:  Julia Scheiermann; Dennis M Klinman
Journal:  Vaccine       Date:  2014-06-24       Impact factor: 3.641

8.  Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns.

Authors:  Hung-Bo Hsiao; Ai-Hsiang Chou; Su-I Lin; I-Hua Chen; Shu-Pei Lien; Chia-Chyi Liu; Pele Chong; Shih-Jen Liu
Journal:  J Virol       Date:  2014-07-30       Impact factor: 5.103

9.  Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis.

Authors:  Mohamed Ameen Ismahil; Tariq Hamid; Shyam S Bansal; Bindiya Patel; Justin R Kingery; Sumanth D Prabhu
Journal:  Circ Res       Date:  2013-11-01       Impact factor: 17.367

10.  Regulatory multitasking of tolerogenic dendritic cells - lessons taken from vitamin d3-treated tolerogenic dendritic cells.

Authors:  Tatjana Nikolic; Bart O Roep
Journal:  Front Immunol       Date:  2013-05-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.